Abstract:Enterotoxigenic Escherichia coli (ETEC) is a major cause of morbidity in children under 5 years of age in low- and middle-income countries and a leading cause of traveler's diarrhea worldwide. The ability of ETEC to colonize the intestinal epithelium is mediated by fimbrial adhesins, such as CS21 (Longus). This adhesin is a type IVb pilus involved in adherence to intestinal cells in vitro and bacterial self-aggregation. Fourteen open reading frames have been proposed to be involved in CS21 assembly, hitherto o… Show more
“…The role of the single minor pilin in initiating pilus assembly was shown previously in the CFA/III and Longus T4b pilus systems of ETEC [98, 99, 108], which are closely related to V . cholerae TCP in sequence, structure, gene synteny and pilus functions [98, 109].…”
Type IV pilus (T4P) systems are complex molecular machines that polymerize major pilin proteins into thin filaments displayed on bacterial surfaces. Pilus functions require rapid extension and depolymerization of the pilus, powered by the assembly and retraction ATPases, respectively. A set of low abundance minor pilins influences pilus dynamics by unknown mechanisms. The Vibrio cholerae toxin-coregulated pilus (TCP) is among the simplest of the T4P systems, having a single minor pilin TcpB and lacking a retraction ATPase. Here we show that TcpB, like its homolog CofB, initiates pilus assembly. TcpB co-localizes with the pili but at extremely low levels, equivalent to one subunit per pilus. We used a micropillars assay to demonstrate that TCP are retractile despite the absence of a retraction ATPase, and that retraction relies on TcpB, as a V. cholerae tcpB Glu5Val mutant is fully piliated but does not induce micropillars movements. This mutant is impaired in TCP-mediated autoagglutination and TcpF secretion, consistent with retraction being required for these functions. We propose that TcpB initiates pilus retraction by incorporating into the growing pilus in a Glu5-dependent manner, which stalls assembly and triggers processive disassembly. These results provide a framework for understanding filament dynamics in more complex T4P systems and the closely related Type II secretion system.
“…The role of the single minor pilin in initiating pilus assembly was shown previously in the CFA/III and Longus T4b pilus systems of ETEC [98, 99, 108], which are closely related to V . cholerae TCP in sequence, structure, gene synteny and pilus functions [98, 109].…”
Type IV pilus (T4P) systems are complex molecular machines that polymerize major pilin proteins into thin filaments displayed on bacterial surfaces. Pilus functions require rapid extension and depolymerization of the pilus, powered by the assembly and retraction ATPases, respectively. A set of low abundance minor pilins influences pilus dynamics by unknown mechanisms. The Vibrio cholerae toxin-coregulated pilus (TCP) is among the simplest of the T4P systems, having a single minor pilin TcpB and lacking a retraction ATPase. Here we show that TcpB, like its homolog CofB, initiates pilus assembly. TcpB co-localizes with the pili but at extremely low levels, equivalent to one subunit per pilus. We used a micropillars assay to demonstrate that TCP are retractile despite the absence of a retraction ATPase, and that retraction relies on TcpB, as a V. cholerae tcpB Glu5Val mutant is fully piliated but does not induce micropillars movements. This mutant is impaired in TCP-mediated autoagglutination and TcpF secretion, consistent with retraction being required for these functions. We propose that TcpB initiates pilus retraction by incorporating into the growing pilus in a Glu5-dependent manner, which stalls assembly and triggers processive disassembly. These results provide a framework for understanding filament dynamics in more complex T4P systems and the closely related Type II secretion system.
“…The crystal structure of CofB in complex with a CofJ N-terminal 24-residue synthetic peptide revealed an unprecedented binding mode, by which the peptide is deeply embedded into the expected GalNAc-binding pocket typically conserved at the trimeric interface of the H-type lectin family ( 25 ). This finding provides a conceptual advance in T4P biology, wherein T4bP anchors the secreted protein at the pilus tip for pathogenesis, as well as a plausible answer for the currently debated association state—either monomeric or trimeric—of the type IVb minor pilin in action ( 24 , 32 – 34 ), based on the evidence that the trimeric association of CofB is prerequisite for its stable interaction with CofJ ( 32 – 35 ).…”
Section: Discussionmentioning
confidence: 88%
“…4 A and B ). The presence of an aromatic patch is commonly observed in PFTs and might act as a multivalent lipid-binding site that recognizes lipid head groups of the cell membrane ( 39 – 41 ), and CofJ reportedly can bind lipid vesicles as well as epithelial cells, such as HeLa and Caco-2 ( 34 ). The lipid-binding nature of CofJ provides advantages for the bacteria by reserving the preferential adhesion spot for initial and/or future attachment to the epithelium as well as in competing with other bacterial species, including commensal species, for subsequent microcolony formation ( Fig.…”
SignificanceTo avoid the mucosal barrier and attach to the intestinal epithelium, enteric pathogens have evolved a unique proteinaceous fiber called type IVb pilus (T4bP). Despite its importance for bacterial pathogenesis, little is known about the adhesion mechanisms of T4bP, especially regarding the role of the minor pilin subunit located at its tip. Here, we show that the type IVb minor pilin CofB of CFA/III from enterotoxigenic Escherichia coli (ETEC) plays a role not only in T4bP assembly by forming a trimeric initiator complex, but also in bacterial adhesion by anchoring a secreted protein, CofJ, at the trimerization interface of H-type lectin domain. These findings expand our knowledge of T4P biology and provide important insights for developing therapeutics against ETEC infection.
“…Indeed, due to the LAB-associated fermented foods, the gut microbiota can also be altered in a positive manner and such foods can thereby assist in the resolution of IBD [ 30 , 31 ]. It has been suggested that fermented dairy products have the ability to positively modulate the gut microbiota, either by stimulating the proliferation of beneficial microbes and/or by introducing novel species into the gut [ 32 , 33 , 34 ]. Other investigators have studied the hypocholesteremic and anti-cancer properties of these LAB-associated fermented as well as non-fermented milks [ 35 ].…”
Consuming fermented foods has been reported to result in improvements in a range of health parameters. These positive effects can be exerted by a combination of the live microorganisms that the fermented foods contain, as well as the bioactive components released into the foods as by-products of the fermentation process. In many instances, and particularly in dairy fermented foods, the microorganisms involved in the fermentation process belong to the lactic acid group of bacteria (LAB). An alternative approach to making some of the health benefits that have been attributed to fermented foods available is through the production of ‘fermentates’. The term ‘fermentate’ generally relates to a powdered preparation, derived from a fermented product and which can contain the fermenting microorganisms, components of these microorganisms, culture supernatants, fermented substrates, and a range of metabolites and bioactive components with potential health benefits. Here, we provide a brief overview of a selection of in vitro and in vivo studies and patents exclusively reporting the health benefits of LAB ‘fermentates’. Typically, in such studies, the potential health benefits have been attributed to the bioactive metabolites present in the crude fermentates and/or culture supernatants rather than the direct effects of the LAB strain(s) involved.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.